Session: Disease Therapies (2009 Annual Meeting)

Description:

This session welcomes contributions addressing the evaluation of therapeutic efficacy of drug delivery systems, stents, or tissue engineered scaffolds. The focus should be on their actual therapeutic potential. Contributions concerning mathematical modeling (or dosimetry) accompanying the above, or suggesting alternative strategies, are also welcome.

Sponsor:

Engineering Fundamentals in Life Science

Chair:

Mariah Hahn
Assistant Professor
Texas A&M University
Chemical Engineering
3122 TAMU
College Station, TX 77843
Phone Number: 979-739-1343
Email: mariah.hahn@chemail.tamu.edu

Co-chairs:

Jennifer Fiegel and Stavroula Sofou

Papers:

253a

In Vivo Evaluation of a Rationally Designed Single Injection Vaccine
Sam N. Rothstein, University of Pittsburgh; Steven R. Little, University of Pittsburgh

253b

Sparse Grid-Based Adaptive Nonlinear Model Predictive Control for Personalizing Drug Regimes
Sarah Noble, Purdue University; Maia Donahue, Purdue University; Caitlin Schmitt, Purdue University; Ann Rundell, Purdue University

253c

Particle Size and the Efficacy of Vascular –Targeted Drug Carriers: Application in Cardiovascular Diseases
Phapanin Charoenphol, University of Michigan; Omolola Eniola-Adefeso, University of Michigan

253d

"Aquaporin-1: Its Presence, Distribution and Quantification in Arterial Endothelium and How These Change with Chronic Hypertension – with Relevance to Early Atherogenesis"
Jimmy Deon Toussaint, City College and the Graduate School and University Center (GSUC) of City University of New York; Tieuvi Nguyen, City College and the Graduate School and University Center (GSUC) of City Uinversity of New York; Stewart Russell, City College and the Graduate School and University Center (GSUC) of City University of New York; Kung-Ming Jan, College of Physician and Surgeons, Columbia University; David Rumschitzki, City College and the Graduate School and University Center (GSUC) of City University of New York

Break

253e

Combinatorial Insulin Secretion Dynamics of Recombinant Hepatic and Intestinal Cells
Kiranmai Durvasula, Georgia Institute of Technology; Peter Thule, Atlanta VA Medical Center; Athanassios Sambanis, Georgia Institute of Technology

253f

Perfecting Bacterial Tumor Treatment Using Microfluidic Bioreactors
Bhushan J. Toley, University of Massachusetts, Amherst.; Brett M. Babin, University of Massachusetts, Amherst.; Neil S. Forbes, University of Massachusetts, Amherst.

253g

Inactivation of Persister Cells by Low-Level Direct Currents
Mi Zhang, Syracuse University; Guifen Luo, Syracuse University; Dacheng Ren, Syracuse University

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division

<< Previous Session | Next Session >>